The Phospholipids market is set to witness a growth rate of 7.3% over the forecast period and be valued at US$ 7.8 Bn by 2032; Fact.MR Analysis

 The global Phospholipids Market was valued at around US$ 3.7 Billion in 2021. With a projected CAGR of 7.3% for the next ten years, the market is likely to reach a valuation of approximately US$ 7.8 Billion by the end of 2032.

Fact.MR’s analysis reveals that most of the phospholipids industry revenue is grossed from Soy as a source which has a predicted CAGR of 7.8% by 2032. Nutrition and Supplements are the top application of these tests, with a CAGR of 7.4% in the forecast period.

For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8089?SP

The readability score of the Phospholipids Market Demand report is good as it offers chapter-wise layout with each section divided into a smaller sections.

The report encompasses graphs and tables to show the entire assembling. Pictorial demonstration of the definite and estimated values of key segments is visually appealing to readers. 

This Phospholipids market outlook report explicates on vital dynamics such as the drivers, restraints and opportunities for key players and competitive analysis of Phospholipids along with key stakeholders as well as emerging players associated with the manufacturing of product.

Competitive Landscape:

Phospholipids providers are focused on increasing the production of their products to meet demand in widespread applications. The key companies operating include Archer Daniels Midland Company, Croda International Plc, Bunge Ltd., Cargill, Inc., Kewpie Corporation, Lasenor Emul SL, Lecico GmbH, Lipoid GmbH, Sime Darby Unimills B.V. SojaProtein, Stern-Wywiol Gruppe, VAV Life Sciences Pvt. Ltd., and Wilmar International Ltd.

Some of the recent development in Phospholipids are as follows:

  • In June 2022, Germany’s LECICO GmbH announced the launching of a soy-sourced phospholipid in the form of phosphatidylcholine. The product was named LIPAMINE PC 30 P IP and was intended for use as a nutraceutical for functional food formulations, as well as an excipient in pharmaceutical and liposomes.
  • In June 2022, Evonik Industries announced an agreement with the US government for the expansion of its capacity to manufacture lipids for use in mRNA therapies both in and beyond COVID vaccines.

Under this agreement, there is a total of US$ 220 Mn as investment, from BARDA, or the Biomedical Research and Development Authority providing US$ 150 Mn, with additional support from the IEDC or Indiana Economic Development Corporation, the GLC or the Greater Lafayette Commerce and Duke Energy.

  • In November 2021, Bunge Loders Croklaan, the natural, plant-based business from Bunge announced plans to build a production facility in the Port of Amsterdam with a 2024 completion goal.
  • In April 2021, VAV Lifesciences through its subsidiary VAV lipids announced an agreement with a US-based Contract Development and Manufacturing or CDMO firm for the supply of phospholipids to be used in mRNA-based COVID vaccine manufacturing. The firm is a vaccine maker for companies like Pfizer-BioNTech and Moderna and will use the phospholipids provided to produce LNPs or Liquid nanoparticles on the behalf of the two.
  • In March 2021, Lecico and Ciranda announced an agreement that grants Ciranda an exclusive distribution agreement in the North American Market.
  • In January 2021, New Zealand’s Fonterra Co-Operative Group Limited launched milk phospholipids sourced from non-GMO rBST-free and grass-fed cows’ milk. This product is intended for the resolution of mental stress and neutraceuticals.

Similarly, recent developments related to companies manufacturing phospholipids have been tracked by the team at Fact.MR, which is available in the full report.

For in-depth competitive analysis, Buy Now:
https://www.factmr.com/checkout/8089?SP

Key Segments Covered in Phospholipids Survey:

·         By Source:

    • Soy
    • Eggs
    • Other Sources

·         By Application:

    • Nutrition and Supplements
    • Pharmaceuticals
    • Other Applications

·         By Region:

    • North America 
    • Latin America 
    • Europe 
    • Asia Pacific 
    • Middle East & Africa 

How will be insights and market estimations provided in the Fact.MR report on the Demand of Phospholipids make a difference?

  • The study takes a closer look at the major economic turmoil, with a focus on the recent COVID-19 pandemic disruptions
  • The assessment of key growth dynamics highlights the attractiveness of new automation technologies and offers readers insight on the prospect of these during the forecast period
  • The study tries to offer a balance perspective of the opportunities in mature and the most lackluster markets
  • Provides scrutiny of the industry trends that have shaped recent government policies
  • Provides an account of major breakthroughs in all segments that might change the course of the market considerably
  • Provides an incisive analysis of socio-political milieu in which the key markets operate, and how will that influence the lucrativeness of the overall Phospholipids  Market
  • Analyzes how collaborations and partnerships among players from different industries shape the key growth dynamics in the near future
  • Evaluates the role of various stages of funding on new growth avenues in key regional markets 

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

 

Comments

Post a Comment

Popular posts from this blog

Automotive Lightweight Material Market Insights

The global automotive lightweight material market has witnessed moderate growth at a CAGR of 3.3% over the past half-decade. However, due to the ongoing outbreak of COVID-19, automotive production has plummeted in quarter Q2 of FY2020, and has cascaded the demand effect towards automotive light weight material. The market is set to decline by more than twofold over the short-term forecast period, owing to prolonged COVID-19 effect on the automotive industry. By the 1st quarter of FY2022, demand for automotive lightweight material is set to resurrect, owing to normalization of automotive production. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=3423?SP Key findings of the Automotive Lightweight Material market study:  Regional breakdown of the Automotive Lightweight Material market based on predefined taxonomy. Innovative manufacturing processes implemented by Automotive Lightweight Material vendors in detail. Region-wise and country-...
Read more

Eyelash Enhancing Agents Market Poised for 5% CAGR Expansion by 2027

Eyelashes enhancing agents market   registered a CAGR of nearly 4.0% between 2013 and 2017. Global sales of eyelashes enhancing agents closed in on US$ 280 Mn in 2018, and are estimated to record a Y-o-Y growth of over 5.0% in 2019. Growing prevalence of Blepharitis, which leads to eye inflammation and affects growth of eyelashes, has favored sales of cosmetic products among the increasing ‘look-conscious’ demographic worldwide, thereby driving demand for eyelashes enhancing agents. The consumers shift towards natural therapies and treatments to prevent side-effects of the chemical-induced agents has led manufacturers to focus on offering a broad array of effective natural eyelashes enhancing agents. For more insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=3588 The readability score of the Eyelashes enhancing agents Market Demand report is good as it offers chapter-wise layout with each section divided into...
Read more

Eucalyptus Oil Market Forecast to Reach at US$ 270 Million by 2033

 The global eucalyptus oil market is poised for substantial growth, with a projected compound annual growth rate (CAGR) of 6.8%. This growth is expected to propel the market from its 2023 valuation of US$ 140 million to reach an impressive US$ 270 million by the conclusion of 2033. Eucalyptus oil, derived from eucalyptus leaves, finds its origins in the lush Australian forests, where eucalyptus trees first emerged. However, in response to heightened demand from various oil producers, these trees are now cultivated worldwide. Eucalyptus oil is obtained through the steam distillation method, which involves carefully selected eucalyptus leaves. The oil offers numerous benefits, including antioxidant protection, stimulation of the immune system, and enhanced respiratory circulation. For more insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=92 Market Drivers: Growing Demand in the Aromatherapy and Pers...
Read more